Tissue targeted antigenic activation of the immune response to treat cancers

HD Gunn - US Patent 8,501,198, 2013 - Google Patents
G01N33/5008—Chemical analysis of biological material, eg blood, urine; Testing involving
biospecific ligand binding methods; Immunological testing involving human or animal cells …

Risk factors for invasive pneumococcal disease

MCJ Schoenmakers, JM Hament, A Fleer… - … and Research in …, 2002 - journals.lww.com
Worldwide, Streptococcus pneumoniae is a pathogen isolated frequently during respiratory
infections and more life-threatening, invasive infections such as sepsis and meningitis …

Tissue targeted antigenic activation of the immune response to treat cancers

HD Gunn - US Patent 9,107,864, 2015 - Google Patents
A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, eg
guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring …

Characterization of Spbhp-37, a Hemoglobin-Binding Protein of Streptococcus pneumoniae

ME Romero-Espejel, MA Rodríguez… - Frontiers in cellular …, 2016 - frontiersin.org
Streptococcus pneumoniae is a Gram-positive microorganism that is the cause of bacterial
pneumonia, sinusitis and otitis media. This human pathogen also can cause invasive …

Tissue targeted antigenic activation of the immune response to cancers

HD Gunn - US Patent 8,034,359, 2011 - Google Patents
Coley's vaccine (a combination of Streptococcus pyogenes and Serratia marcescens) has
been reported to be helpful for the treatment of sarcomas, and lymphomas (Nauts HC …

Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South …

MJ Choi, SO Kang, JJ Oh, SB Park, MJ Kim… - Human Vaccines & …, 2018 - Taylor & Francis
ABSTRACT In South Korea, the National Immunization Program offers a 23-valent
pneumococcal polysaccharide vaccine (PPSV23) for the elderly; however, the 13-valent …

Cost-effectiveness of vaccinating for invasive pneumococcal disease in the elderly in the Lazio region of Italy

M Merito, PG Rossi, J Mantovani, F Curtale, P Borgia… - Vaccine, 2007 - Elsevier
Pneumococcal vaccination among the elderly is currently recommended in several western
countries. We estimated the cost-effectiveness of a hypothetical vaccination campaign of …

[HTML][HTML] Molecular Characterization of Streptococcus Pneumoniae from Patients Diagnosed with Pneumonia: Recommendation for Vaccination Program

A Esteghamati, A Nazari-Alam… - Medical Journal of the …, 2022 - ncbi.nlm.nih.gov
Background: Infections caused by Streptococcus pneumoniae (S. pneumoniae) have
remained a significant public health concern worldwide. In developed countries, the highest …

Pneumococcal vaccination of the elderly during visits to acute care providers: Who are vaccinated?

D Sabapathy, D Strong, R Myers, B Li, H Quan - Preventive medicine, 2014 - Elsevier
Objective Many elderly remain unvaccinated against invasive pneumococcal disease yet
frequently visit acute care providers where they have an opportunity to receive the …

Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions

JF Bernardo, J McCauley - Drugs & aging, 2004 - Springer
Elderly patients with end-stage organ failure are now more frequently undergoing
transplantation. Medication management in this population is challenging because of the …